VALIANT LABORATORIES
Back to Balance Sheet
|
VALIANT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Current Liabilities | ₹60 Cr | ₹29 Cr | ₹51 Cr |
What is the latest Total Current Liabilities ratio of VALIANT LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹60 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹51 Cr |
How is Total Current Liabilities of VALIANT LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹60 Cr | 105.03 | |
| Mar2024 | ₹29 Cr | -42.68 | |
| Mar2023 | ₹51 Cr | - | |
Compare Total Current Liabilities of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹665.7 Cr | -2.4% | 33.9% | 39.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,716.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,120.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,038.0 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| CIPLA | ₹110,858.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,828.7 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -2.4% |
33.9% |
39.2% |
| SENSEX | -0.6% |
-4.4% |
-8.7% |
You may also like the below Video Courses